Latest Breaking News On - Noveome biotherapeutics inc - Page 1 : comparemela.com
Noveome Biotherapeutics, Inc Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Noveome Biotherapeutics, Inc Commences Phase 1 Clinical Study of ST266 Application for Infectious Disease (including COVID-19)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Noveome Biotherapeutics, Inc Announces Christopher J P Velis as Chief Executive Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Periodontal Disease Therapeutics Market 2021 | Global Industry Size, Share, Regional Analysis, Growt
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Noveome Biotherapeutics, Inc. Makes New Appointment to Board of Directors
March 8, 2021 GMT
PITTSBURGH (BUSINESS WIRE) Mar 8, 2021
Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed Christopher J. P. Velis to the company’s Board of Directors.
Mr. Velis is an entrepreneur and venture capitalist who has pioneered some of the most innovative medical technologies brought to market in the last decades. As Founder and Executive Chairman of Miraki Innovation, he forecasts imminent global health and medical challenges, uncovers technologies at leading research institutions and assembles teams of industry experts to solve these global problems. Mr. Velis not only offers investment guidance and critical research and industry connections, but also he